is melanotan a peptide II (MT-II) Therapy Melanotan II | Research Peptide
Description
A recent meta-analysis of randomized controlled trials (n338) reported a statistically significant reduction in core ASD symptoms (standardized mean difference0.67) following KD interventions (Yu et al., 2022)
Approximately 22 people worked 7,065 hours on this project
Saimbert Henry J
Yokoyama A, Ishii H, Takagi T, Hori S, Matsushita S, Onishi S, et al
